Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 28;12:1029960. doi: 10.3389/fonc.2022.1029960

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Wan, Ding, Mao, Ma, Li, Xiao, Qian, Jiang, Zheng, Wu, Teng and Xu

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Kaplan–Meier survival curves in the clinical trial cohort stratified by inflammatory markers for (A) PFS for NLR cut-off, (B) OS for NLR cut-off, (C) PFS for MLR cut-off, (D) OS for MLR cut-off, (E) PFS for PLR cut-off, (F) OS for PLR cut-off, (G) PFS for SII cut-off, (H) OS for SII cut-off, (I) PFS for dNLR cut-off and (J) OS for dNLR cut-off. The p values were calculated using the log-rank test (two-sided). CI, confidence interval; dNLR, derived neutrophil-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio; OS, overall survival; PLR, platelet-to-lymphocyte ratio; PFS, progression-free survival; SII, systemic immune-inflammation index.